共 50 条
Synthesis of hemslecin A derivatives: A new class of hepatitis B virus inhibitors
被引:17
|作者:
Guo, Rui-Hua
[1
]
Geng, Chang-An
[1
]
Huang, Xiao-Yan
[1
]
Ma, Yun-Bao
[1
]
Zhang, Quan
[1
]
Wang, Li-Jun
[1
]
Zhang, Xue-Mei
[1
]
Zhang, Rong-Ping
[2
]
Chen, Ji-Jun
[1
]
机构:
[1] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China
[2] Kunming Med Univ, Kunming 650500, Yunnan, Peoples R China
基金:
中国国家自然科学基金;
关键词:
Hemslecin A;
Derivatives;
Hepatitis B virus;
SCHISANDRA-WILSONIANA;
FRUITS;
ALISOL;
D O I:
10.1016/j.bmcl.2013.01.024
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
A series of hemslecin A derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities, namely, inhibiting the secretion of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and HBV DNA replication on HepG 2.2.15 cells. Most of the derivatives showed enhanced anti-HBV activities, of which compounds A1-A7, B5, C and E exhibited significant activities inhibiting HBV DNA replication with IC50 values of 2.8-11.6 mu M, comparable to that of the positive control, tenofovir. Compounds A1-A3, A5, B5, and C displayed low cytotoxicities, which resulted in high SI values of 89.7, 55.6, 77.8, >83.4, >55.8, and >150.5, respectively. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1201 / 1205
页数:5
相关论文